Please login or register to print this page.

Clinical Articles, News & Views

PREFER in AF patient registry extended

The PREFER in AF (PREvention oF thromboembolic events – European Registry in Atrial Fibrillation) registry has been extended to include a special focus on the use of novel oral anticoagulant (NOAC) therapy including prescribing patterns, providing new insight into the long-term management of patients with atrial fibrillation (AF).

The PREFER in AF Registry was initially conducted in seven European countries with over 7,000 patients to gain detailed insight into the characteristics and management of AF, with a focus on the prevention of thromboembolic events, and in particular, stroke. This extension to the registry will collect additional up-to-date real life data from approximately 5,000 patients across more than 320 centres in nine European countries, including the addition of two new countries; Belgium and The Netherlands.

“Despite the introduction of a number of NOACs there remains a lack of data on current management of AF patients in clinical practice settings. The PREFER in AF registry enables us to observe and understand different anticoagulation treatment patterns, giving us a valuable and much needed insight into the long-term management of patients with AF and specifically the use of NOACs,” said Professor Paulus Kirchhof (University of Birmingham), Chair of the PREFER in AF Steering Committee. “It is critical that patients with AF who are at risk of experiencing stroke and thromboembolism maintain effective anticoagulation – and this extended registry will provide vital data to support clinicians with their prescribing decisions,” he added.

Further results from the PREFER in AF initial registry period are due to be presented later this year.

Published on: April 30, 2014

Members Area

Log in or Register now.

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

ENDORSED BY

  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.